Gainers
- Lixte Biotech Hldgs (NASDAQ:LIXT) stock increased by 13.5% to $4.45 during Wednesday's after-market session. The market value of their outstanding shares is at $8.2 million.
- Align Tech (NASDAQ:ALGN) shares moved upwards by 12.84% to $383.5. Align Tech's trading volume hit 77.4K shares by close, accounting for 10.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $29.3 billion. The company's, Q2 earnings came out today.
- Mallinckrodt (AMEX:MNK) shares moved upwards by 9.52% to $1.38. This security traded at a volume of 4.2 million shares come close, making up 254.1% of its average volume over the last 100 days. The company's market cap stands at $18.1 million.
- AIM ImmunoTech (AMEX:AIM) shares moved upwards by 6.43% to $0.61. The company's market cap stands at $29.5 million.
- Celularity (NASDAQ:CELU) shares increased by 5.68% to $0.37. Trading volume for this security closed at 163.6K, accounting for 25.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $66.7 million.
- Intensity Therapeutics (NASDAQ:INTS) stock moved upwards by 5.24% to $6.22. The market value of their outstanding shares is at $85.1 million.
Losers
- Aceragen (NASDAQ:ACGN) shares declined by 9.3% to $0.81 during Wednesday's after-market session. The market value of their outstanding shares is at $6.8 million.
- Infinity Pharmaceuticals (NASDAQ:INFI) stock declined by 7.86% to $0.13. The company's market cap stands at $11.5 million.
- Edwards Lifesciences (NYSE:EW) shares declined by 6.17% to $85.98. Trading volume for this security closed at 229.9K, accounting for 8.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $52.1 billion. The company's, Q2 earnings came out today.
- Plus Therapeutics (NASDAQ:PSTV) stock declined by 5.64% to $2.51. The company's market cap stands at $6.2 million.
- icad (NASDAQ:ICAD) shares declined by 5.61% to $3.2. The market value of their outstanding shares is at $81.4 million.
- Bellerophon Therapeutics (NASDAQ:BLPH) stock fell 5.4% to $0.44. This security traded at a volume of 81.3K shares come close, making up 13.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $4.5 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.